SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 147.20 |
| Enterprise Value ($M) | 90.78 |
| Book Value ($M) | 94.87 |
| Book Value / Share | 1.28 |
| Price / Book | 1.55 |
| NCAV ($M) | 94.72 |
| NCAV / Share | 1.27 |
| Price / NCAV | 1.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -2.49 |
| Return on Equity (ROE) | -4.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 26.37 |
| Current Ratio | 26.37 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 98.45 |
| Assets | 98.60 |
| Liabilities | 3.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -28.59 |
| Net Income | -27.52 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -19.15 |
| Cash from Investing | -37.00 |
| Cash from Financing | 103.48 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Point72 Asset Management, L.P. | 0.00 | -100.00 | |
| 13G/A | Armistice Capital, Llc | 4.99 | 365.03 | |
| 13G | ADAR1 Capital Management, LLC | 9.99 | ||
| 13G/A | Fairmount Funds Management LLC | 9.90 | 6.02 | |
| 13G | Nantahala Capital Management, LLC | 7.54 | ||
| 13G | Soleus Private Equity Fund III, L.P. | 9.99 | ||
| 13G | SP IKT Holdings LLC | 8.69 | ||
| 13G | Sands Capital Life Sciences Pulse Fund II, L.P. | 16.30 | ||
| 13G | Perceptive Advisors Llc | 9.99 | ||
| 13G | Commodore Capital Lp | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,875 | 153,900 | 10.96 | |
| 26,467 | 121,825 | 21.73 | |
| 22,064 | 98,996 | 22.29 | |
| 35,029 | 186,022 | 18.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HRTX – Heron Therapeutics, Inc. | IBIO – iBio, Inc. |
| ICCC – ImmuCell Corporation | IMCC – IM Cannabis Corp. |
| IMMX – Immix Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io